Continued rapid growth in Ga-68 applications: update 2013 to June 2014
2015 (English)In: Journal of labelled compounds & radiopharmaceuticals, ISSN 0362-4803, E-ISSN 1099-1344, Vol. 58, no 3, 99-121 p.Article, review/survey (Refereed) Published
The worldwide utilization of Ga-68-radionuclide for the fundamental research and clinical applications is growing exponentially. A broad range of Ga-68-based imaging agents has been explored during recent years. The development of new clinically useful agents is encouraged by many factors; for example, increasing role of positron emission tomography (PET) in nuclear medicine, discovery of new biomarkers, accessibility of Ga-68, and establishment of PET radiopharmaceutical regulation and legislation. The focus of this review resides on the reports regarding Ga-68-related research and applications published during 2013 to June 2014.
Place, publisher, year, edition, pages
2015. Vol. 58, no 3, 99-121 p.
positron emission tomography, Ga-68, chemistry, receptor targeting, peptide, perfusion, ventilation
Other Chemistry Topics
IdentifiersURN: urn:nbn:se:uu:diva-252464DOI: 10.1002/jlcr.3250ISI: 000351764300007PubMedID: 25689590OAI: oai:DiVA.org:uu-252464DiVA: diva2:810524